Every story and comment from the Hacker News API, in a layout borrowed from 2001.
A comment on Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for Breast Cancer. Parent comment
If a company or research group wants to sponsor an experimental treatment with patient approval and waiver free of charge, that's one thing.
But they almost immediately turn around and say " oh we'll need to cover costs..." and suddenly the incentive is very different.
There are no comments on this comment yet.
If a company or research group wants to sponsor an experimental treatment with patient approval and waiver free of charge, that's one thing.
But they almost immediately turn around and say " oh we'll need to cover costs..." and suddenly the incentive is very different.